Aspire Biopharma Holdings, INC. (ASBP) — 8-K/A Filings
All 8-K/A filings from Aspire Biopharma Holdings, INC.. Browse 1 Amended Current Event Report reports with AI-powered summaries and risk analysis.
8-K/A Filings (1)
-
Aspire Biopharma Files 8-K/A Amendment
— Apr 17, 2026 Risk: medium
Aspire Biopharma Holdings, Inc. filed an amendment (8-K/A) on April 17, 2026, to its previous filing. This amendment pertains to Item 1.01 (Entry into a Materia
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX